From the bench of molecular understanding to the bedside of optimal therapy for BCR::ABL1 and ABL-class acute lymphoblastic leukemia in children and adolescents
This review aims to discuss similarities and dissimilarities between BCR::ABL1-rearranged (Philadelphia chromosome-positive [Ph+]) and ABL-class fusion-driven BCR::ABL1-like (Ph-like) acute lymphoblastic leukemia (ALL) in children and adolescents. Recent insights into the biology of these historical...
Saved in:
Main Authors: | Sarah K. Tasian, Judith M. Boer, Monique L. den Boer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-12-01
|
Series: | EJC Paediatric Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772610X25000923 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BCR-ABL gene amplification in patients with chronic myeloid leukemia and imatinib resistance
by: S. I. Kutzev, et al.
Published: (2022-11-01) -
The comparative analysis of BCR-ABL/ABL detection by real-time quantitative PCR and automated GeneXpert Dx System in chronic myeloid leukemia patients with major and complete molecular response
by: S. A. Smirnikhina, et al.
Published: (2014-07-01) -
BCR‐ABL enhances the prolyl isomerase activity of Pin 1 by interacting with DAPK1 in ph+ ALL
by: Wen‐bin Cao, et al.
Published: (2018-06-01) -
Targeting HSPA8 to repress GPX4 and induce ferroptosis in BCR-ABL positive leukemia
by: Shuxin Zhong, et al.
Published: (2025-09-01) -
Computational Insights into the Polypharmacological Landscape of BCR-ABL Inhibitors: Emphasis on Imatinib and Nilotinib
by: Rima Hajjo, et al.
Published: (2025-06-01)